Belmont Global Advisors’s Aceragen Inc ACGN Stock Holding History

Belmont Global Advisors’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,840	Closed	-$495K	–	85
2016 Q1	$495K	Buy	+1,840	New	+$492K	0.5%	37

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Belmont Global Advisors's ACGN Position: Q2 2016 in Review

Belmont Global Advisors sold out of Aceragen Inc (ACGN) in Q2 2016, closing a stake of 1,840 shares — an estimated $495K sold.

Belmont Global Advisors first reported a position in ACGN in Q1 2016 and held it in 1 quarter. The position peaked at $495K in Q1 2016. 76 funds tracked by Wall St. Rank hold ACGN as of Q2 2016.

Belmont Global Advisors reported no remaining Aceragen Inc position as of Q2 2016 after selling out during the quarter.
Belmont Global Advisors sold 1,840 Aceragen Inc shares in Q2 2016, an estimated $495K.
Belmont Global Advisors first reported a position in Aceragen Inc in Q1 2016 and held it in 1 quarter.
Belmont Global Advisors's Aceragen Inc position peaked at $495K in Q1 2016.
76 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2016.

Based on Belmont Global Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.